|
Jul 17
|
Trinity Life Sciences Unveils Breakthrough AI Model That Detects Type 1 Diabetes a Year Before Symptoms Appear
|
|
Jul 17
|
Thermo Fisher acquires Sanofi’s steriles manufacturing site in US
|
|
Jul 17
|
Press Release: Sanofi announces extension of Blueprint tender offer
|
|
Jul 16
|
Sanofi's Gene Therapy for Eye Disease Gets FDA's Fast Track Tag
|
|
Jul 16
|
Can Recursion Pharmaceuticals' Strategic Deals Fuel Long-Term Growth?
|
|
Jul 16
|
Thermo Fisher acquires Sanofi's New Jersey manufacturing site
|
|
Jul 16
|
Thermo Fisher Scientific and Sanofi Expand Strategic Partnership to Enable Additional U.S. Drug Product Manufacturing
|
|
Jul 16
|
Press Release: Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration
|
|
Jul 15
|
Chronic Rhinosinusitis with Nasal Polyps Market Analysis and Forecast Report 2025-2035, Featuring AstraZeneca, Amgen, GlaxoSmithKline, Keymed Biosciences, Biohaven Pharmaceuticals, Sanofi, and More
|
|
Jul 14
|
Biotech Stocks Are Ready to Rebound. Gilead Sciences and 2 More to Watch Now.
|
|
Jul 14
|
Europe Glucagon-like Peptide-1 (GLP-1) Agonists Research Report 2025 | Market to Reach $14.34 Billion by 2034, Driven by Innovative R&D, Strategic Collaborations, and Drug Formulation Advancements
|
|
Jul 12
|
FDA willing to trade faster drug reviews for lower prices, Bloomberg reports
|
|
Jul 1
|
10 European Dividend Stocks That Could Beat Their U.S. Counterparts
|
|
Jul 1
|
Sanofi’s riliprubart gains ODD status from Japan’s MHLW for CIDP
|
|
Jul 1
|
Sector Update: Health Care Stocks Lean Lower Premarket Tuesday
|
|
Jul 1
|
Adagene announces up to $25 million strategic investment from Sanofi
|
|
Jun 30
|
Sanofi (ENXTPA:SAN) Gains Orphan Drug Status In Japan For CIDP Treatment
|
|
Jun 30
|
Hedge Fund Strategy Built on Catastrophes Taps Hot New Trend
|
|
Jun 30
|
ESTEVE to acquire medicine to treat medullary thyroid cancer
|
|
Jun 30
|
Press release: Availability of the Q2 2025 Aide mémoire
|